Afatinib 40 mg is a once-daily targeted therapy for patients with non-small cell lung cancer (NSCLC) who have EGFR mutations. It works by blocking the signals that help cancer cells grow and spread. Trusted worldwide, Afatinib is now available in affordable generic form through LetsMeds, making treatment more accessible in the Philippines.

Note: This is for educational purposes only. Always consult your doctor before starting any medication. Common side effects may include diarrhea, rash, or mouth sores.

Learn more or place an order:

🌐 www.letsmeds.com/afatinib-40-mg-tablet-philippines

📱 WhatsApp/Viber: +91-7428091874

📧 letsmeds@gmail.com

#Afatinib #LungCancer #NSCLC #Philippines #LetsMeds